Eric Lang - Jun 14, 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Chief Medical Officer
Signature
/s/ Eric Lang
Stock symbol
CHRO
Transactions as of
Jun 14, 2024
Transactions value $
$0
Form type
4
Date filed
6/18/2024, 08:05 PM
Previous filing
Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRO Stock Option Award +130K +536.68% 154K Jun 14, 2024 Common Stock 130K $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 14, 2024, the Reporting Person was granted stock options to purchase 130,000 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.